Showing 20 of 30 recruiting trials for “upper-tract-urothelial-carcinoma”
Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma (T-LND UTUC): A Randomized Clinical Trial
👨⚕️ Changyi Quan, MD, Tianjin Medical University Second Hospital📍 1 site📅 Started Jan 2026View details ↗
RecruitingNCT07452432 ↗
Korean Prospective Upper Tract Urothelial Carcinoma Cohort
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC
Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Cisplatin-eligible Upper Tract Urothelial Cancer
Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC
👨⚕️ Hailong Hu, PhD, Tianjin Medical University Second Hospital📍 1 site📅 Started Jul 2025View details ↗
Ambulatory Flexible URS for UTUC Surveillance
Low-grade UTUC Treated With Nadofaragene Firadenovec Administered to Renal Pelvis
Urine Methylation Markers in UTUC
9MW2821 + Toripalimab vs 9MW2821 for 1st Line Locally Advanced or Metastatic Urothelial Carcinoma
Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients
Multicenter Clinical Trial of ST-02 for Ablation of Upper Tract Urothelial Carcinoma
Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma
👨⚕️ Mohamed Eltemamy, MD, Cleveland Clinic, Glickman Urological and Kidney Institute, Case Comprehensive Cancer Center📍 4 sites📅 Started May 2024View details ↗
RecruitingNCT06991868 ↗
A Multicenter Prospective Cohort Study on Monitoring Recurrence of Urothelial Carcinoma Based on Detection of Urinary Microscopic Residual Disease (MRD)
A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical Surgery
RecruitingNCT06310759 ↗
Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
RecruitingNCT06204406 ↗
Prognosis of Patients With Upper Tract Urothelial Carcinoma Receiving Kidney-sparing Therapy
Combination of DV and Tislelizumab for Renal Preservation in High-risk UTUC Patients
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract
👨⚕️ Scot Niglio, MD, MS, Memorial Sloan Kettering Cancer Center📍 8 sites📅 Started Jun 2023View details ↗
POST URS Chemotherapy Instillation
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →